Document:

ste06302022ex103

    Exhibit 10.3  DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT  This Director and Officer Indemnification Agreement, dated as of                 , 20   (this “Agreement”), is made by  and between STERIS Corporation, an Ohio corporation (the “Company”), and                  (“Indemnitee”).  RECITALS:  A.     In recognition of the need for corporations to be able to induce capable and responsible persons to accept  and continue in positions in corporate management, Ohio law authorizes (and in some instances requires)  corporations to indemnify, and purchase and maintain insurance for the benefit of, their directors and officers, and  persons serving at the request of corporations as directors and officers of other entities (each director or officer, a  “corporate official”).  B.     Indemnification by a corporation serves the policies of (1) allowing corporate officials to resist  unjustified lawsuits, secure in the knowledge that, if vindicated, the corporation will bear the expense of litigation,  (2) encouraging capable women and men to serve as corporate officials, secure in the knowledge that the  corporation will absorb the costs of defending their honesty and integrity, (3) allowing corporate officials to dispose  of vexatious and distracting litigation through negotiation and settlements, and (4) authorizing corporations to  purchase and maintain insurance for the benefit of corporate officials.  C.     Ohio law also authorizes a corporation to pay in advance of the final disposition of an action, suit or  proceeding the expenses incurred by a corporate official, and any such right to the advancement of expenses may be  made separate and distinct from any right to indemnification and need not be subject to the satisfaction of any  standard of conduct or otherwise affected by the merits of any claims against the corporate official.  D.     Legislative and regulatory initiatives have also exposed corporate officials to a significantly greater risk  of criminal proceedings, with attendant defense costs and potential criminal fines and penalties.  E.     Under Ohio law, a corporate official’s right to be reimbursed for the costs of defense of criminal actions  does not depend upon the merits of the claims asserted against the corporate official and indemnification of the  corporate official against criminal fines is permitted if the corporate official satisfies the applicable standard of  conduct.  F.     Indemnitee is a director and/or officer of (1) STERIS plc, an entity organized under the laws of Ireland  (“STERIS”), and the indirect ultimate, parent of the Company and/or (2) the Company, and Indemnitee’s  willingness to serve in such capacity is predicated, in substantial part, upon the Company’s willingness to indemnify  Indemnitee in accordance with the principles reflected above, to the fullest extent permitted by the laws of the State  of Ohio, and upon the other undertakings set forth in this Agreement.  G.     The code of regulations of the Company provides that the Company shall indemnify certain individuals  who may be party to threatened, pending or completed claims by reason of their status as a corporate official of the  Company and for the prepayment, advancement or reimbursement by the Company of certain expenses incurred in  connection with such claims.  H.    Therefore, in recognition of the need to provide Indemnitee with contractual protection against personal  liability, in order to procure Indemnitee’s continued service as a director and/or officer of STERIS and/or the  Company and to enhance Indemnitee’s ability to serve STERIS and/or the Company in an effective manner to the  benefit of the Company, and in order to provide such protection pursuant to express contract rights (intended to be  enforceable irrespective of, among other things, any amendment to any provisions relating to indemnification  included in the Constituent Documents (as defined below), any change in the composition of the board of directors  of the Company or the Board (as defined below), any change-in-control or business combination transaction relating  to the Company and/or STERIS, or any change in the director’s or officer’s status through retirement or resignation),  

 

NAI-1509358470v3     2    the Company wishes to provide for the indemnification of and the advancement of Expenses (as defined below) to  Indemnitee as set forth in this Agreement and for the continued coverage of Indemnitee under the Company’s  directors’ and officers’ liability insurance policies or, to the extent applicable, any similar policies of STERIS.  I.     In light of the considerations referred to in the preceding recitals, it is the Company’s intention and desire  that the provisions of this Agreement be construed liberally, subject to their express terms, to maximize the  protections to be provided to Indemnitee hereunder.     AGREEMENT:  NOW, THEREFORE, the parties hereby agree as follows:       1. Certain Definitions. In addition to terms defined elsewhere herein, the following terms have the following  meanings when used in this Agreement:       (a) “Affiliate” means “affiliate” as defined in Rule 12b-2 promulgated under Section 12 of the  Exchange Act.         (b) “Assets” means the assets of any kind owned by STERIS, including without limitation, the  securities of the Subsidiaries of STERIS and any of the assets owned by the Subsidiaries of  STERIS.       (c) “Beneficial Owner”, “Beneficial Ownership” or “Beneficially Owns”  has the meaning set forth  in Rule 13d-3 under the Exchange Act.       (d) “Board” means the board of directors of STERIS.      (e) “Change in Control” means the occurrence of any event set forth in any one of the following  paragraphs subsequent to the date hereof:  (1) Any Person becomes the Beneficial Owner, directly or indirectly, of 20% or more of  either: (A) the then issued ordinary shares in the capital of STERIS (the “Outstanding  STERIS Issued Shares”); or (B) the combined voting power of the then outstanding  voting securities of STERIS entitled to vote generally in the election of directors at  general meetings of STERIS (the “Outstanding STERIS Voting Securities”), excluding  any Person who becomes such a Beneficial Owner in connection with a transaction that  complies with clauses (A), (B) and (C) of paragraph (3) of this subsection (e); provided,  however, that the following transactions shall not constitute a Change in Control:    (i) any acquisition by a Person of Outstanding STERIS Issued Shares or  Outstanding STERIS Voting Securities directly from STERIS that is approved  by a majority of the Incumbent Board (as defined below);    (ii) any acquisition by a Person of Beneficial Ownership of 20% or more of the  Outstanding STERIS Issued Shares or Outstanding STERIS Voting Securities  as a result of a reduction in the number of shares of Outstanding STERIS  Issued Shares or Outstanding STERIS Voting Securities, unless and until such  Person thereafter becomes the Beneficial Owner of any additional shares of  Outstanding STERIS Issued Shares or Outstanding STERIS Voting Securities  representing 1% or more of the then-outstanding Outstanding STERIS Issued  Shares or Outstanding STERIS Voting Securities, other than an acquisition  directly from STERIS that is approved by a majority of the Incumbent Board,  or other than as a result of a stock dividend, stock split or similar transaction  effected by STERIS in which all holders of Outstanding STERIS Issued Shares  or Outstanding STERIS Voting Securities are treated equally; and     

 

NAI-1509358470v3     3    (iii) any acquisition by a Person of Beneficial Ownership of 20% or more of the  Outstanding STERIS Issued Shares or Outstanding STERIS Voting Securities  that at least a majority of the Incumbent Board determines in good faith has  occurred inadvertently and such Person divests, as promptly as reasonably  practicable, a sufficient number of shares so that such Person Beneficially  Owns less than 20% of the Outstanding STERIS Issued Shares or Outstanding  STERIS Voting Securities, as applicable.  (2) If (i) on or prior to the date that is two years after the date hereof, individuals who  constituted the Board as of the date hereof or (ii) after the date that is two years after the date  hereof, individuals who constituted the Board two years prior to any date of determination (in each  case, the “Incumbent Board”) for any reason cease to constitute at least two-thirds of the Board,  provided however, that any individual becoming a director subsequent to the beginning of such  two-year period whose election, or nomination for election by STERIS’s shareholders, was  approved by a vote of at least two-thirds of the then Incumbent Board shall be deemed to be a  member of the Incumbent Board, but excluding, for this purpose, any individual whose initial  assumption of office occurs as a result of an actual or threatened election contest with respect to  the election or removal of directors or any other actual or threatened solicitation of proxies or  consents by or on behalf of a Person other than the Board;   (3) the consummation of an acquisition, reorganization, reincorporation, redomestication,  merger, amalgamation, consolidation, plan or scheme of arrangement, exchange offer, business  combination or similar transaction of STERIS or any of its Subsidiaries or the sale, transfer or  other disposition of all or substantially all of the Assets (any of which a “Corporate Transaction”),  unless, following such Corporate Transaction or series of related Corporation Transactions, as the  case may be: (A) all of the individuals and Entities who were the Beneficial Owners respectively,  of the Outstanding STERIS Issued Shares and Outstanding STERIS Voting Securities  immediately prior to such Corporate Transaction own or beneficially own, directly or indirectly,  more than two-thirds of, respectively, the Outstanding STERIS Issued Shares and the combined  voting power of the Outstanding STERIS Voting Securities, as the case may be, of the Entity  resulting from such Corporate Transaction (including, without limitation, an Entity (including any  new parent Entity), which, as a result of such transaction, owns STERIS or all or substantially all  of the Assets either directly or through one or more Entities) in substantially the same proportions  as their ownership, immediately prior to such Corporate Transaction, of the Outstanding STERIS  Issued Shares and the Outstanding STERIS Voting Securities, as the case may be; (B) no Person  (excluding any Entity resulting from such Corporation Transaction or any employee benefit plan  (or related trust) of the Company or such Entity resulting from such Corporate Transaction)  Beneficially Owns, directly or indirectly, 20% or more of, respectively, the then issued ordinary  shares (or outstanding shares of common stock) of the Entity resulting from such Corporate  Transaction or the combined voting power of the then outstanding voting securities of such Entity,  except to the extent that such ownership existed prior to the Corporate Transaction; and (C) at  least two-thirds of the members of the board of directors (or other governing body) of the Entity  resulting from such Corporate Transaction were members of the Incumbent Board at the time of  the approval of such Corporate Transaction; or   (4) approval or adoption by the Board or the shareholders of STERIS of a plan or proposal  that could result directly or indirectly in the liquidation or dissolution, transfer, sale or other  disposal of all or substantially all of the Assets or the dissolution of STERIS, excluding any  transaction that complies with clauses (A), (B) and (C) of paragraph (3) above.        (f) “Claim” means (i) any threatened, asserted, pending or completed claim, demand, action, suit or  proceeding of any kind, whether civil, criminal, administrative, arbitrative, investigative or  other, and whether made pursuant to federal, state or other law; and (ii) any threatened, pending  or completed inquiry or investigation, whether made, instituted or conducted by or at the behest  of STERIS, STERIS UK or the Company or any other person, including any federal, state or  other court or governmental entity or agency and any committee or other representative of any  

 

NAI-1509358470v3     4    corporate constituency, that Indemnitee determines might lead to the institution of any such  claim, demand, action, suit or proceeding.       (g) “Constituent Documents” means the Company’s articles of incorporation and code of  regulations and STERIS’s Memorandum of Association and Articles of Association.       (h) “Disinterested Director” means a director of the Company who is not and was not a party to the  Claim in respect of which indemnification is sought by Indemnitee.    (i) “Entity” means any corporation, partnership, association, joint-stock company, limited liability  company, trust, unincorporated organization or other business entity;        (j) “ERISA Losses” means any taxes, penalties or other liabilities under the Employee Retirement  Income Security Act of 1974, as amended, or Section 4975 of the Internal Revenue Code of  1986, as amended.       (k) “Exchange Act” means the Securities Exchange Act of 1934, as amended.        (l) “Expenses” means attorneys’ and experts’ fees and expenses and all other costs and expenses  paid or payable in connection with investigating, defending, being a witness in, responding to or  participating in (including on appeal), or preparing to investigate, defend, be a witness in,  respond to or participate in (including on appeal), any Claim, any federal, state, local or foreign  income tax(es) paid or payable by the Indemnitee as a result of the actual or deemed receipt of  any payments under this Agreement, and any amounts paid in settlement prior to a final,  nonappealable judgment or conviction.        (m) “Indemnifiable Claim” means any Claim based upon, arising out of or resulting from (i) any  actual, alleged or suspected act or failure to act by Indemnitee in his or her capacity as a director,  officer, employee or agent of the Company or as a director, officer, employee, member,  manager, trustee or agent of any other corporation, limited liability company, partnership, joint  venture, trust or other entity or enterprise, whether or not for profit (including any employee  benefit plan or related trust), as to which Indemnitee is or was serving at the request of the  Company as a director, officer, employee, member, manager, trustee or agent, including, but not  limited to, STERIS and STERIS UK, (ii) any actual, alleged or suspected act or failure to act by  Indemnitee in respect of any business, transaction, communication, filing, disclosure or other  activity of the Company or any other entity or enterprise referred to in clause (i) of this sentence  or (iii) Indemnitee’s status as a current or former director, officer, employee or agent of the  Company or as a current or former director, officer, employee, member, manager, trustee or  agent of the Company or any other entity or enterprise referred to in clause (i) of this sentence,  or any actual, alleged or suspected act or failure to act by Indemnitee in connection with any  obligation or restriction imposed upon Indemnitee by reason of such status. In addition to any  service at the actual request of the Company, for purposes of this Agreement, Indemnitee will be  deemed to be serving or to have served at the request of the Company as a director, officer,  employee, member, manager, trustee or agent of another entity or enterprise if Indemnitee is or  was serving as a director, officer, employee, member, manager, trustee or agent of such entity or  enterprise and (i) such entity or enterprise is or at the time of such service was an Affiliate of the  Company, (ii) such entity or enterprise is or at the time of such service was an employee benefit  plan (or related trust) sponsored or maintained by the Company or an Affiliate of the Company,  or (iii) the Company or an Affiliate of the Company directly or indirectly caused or authorized  Indemnitee to be nominated, elected, appointed, designated, employed, engaged or selected to  serve in such capacity.  Without limiting the generality of the foregoing, the parties acknowledge  and agree that Indemnitee is, or will be serving, at the request of Company, as a director or  officer of STERIS and served at the request of Company as a director or officer of STERIS UK.       (n) “Indemnifiable Losses” means any and all Losses relating to, arising out of or resulting from  any Indemnifiable Claim.        (o) “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in  matters of corporation law and neither presently is, nor in the past five years has been, retained  to represent: (i) the Company, STERIS UK or STERIS (or any Subsidiary) or Indemnitee in any  

 

NAI-1509358470v3     5    matter material to either such party (other than with respect to matters concerning Indemnitee  under this Agreement, or of other indemnitees under similar indemnification agreements), or  (ii) any other named (or, as to a threatened matter, reasonably likely to be named) party to the  Indemnifiable Claim giving rise to a claim for indemnification hereunder. Notwithstanding the  foregoing, the term “Independent Counsel” will not include any person who, under the  applicable standards of professional conduct then prevailing, would have a conflict of interest in  representing any of the Company, STERIS UK, STERIS or Indemnitee in an action to determine  Indemnitee’s rights under this Agreement.        (p) “Losses” means any and all Expenses, damages, losses, liabilities, judgments, fines, penalties  (whether civil, criminal or other), ERISA Losses and amounts paid in settlement, including, but  not limited to, all interest, assessments and other charges paid or payable in connection with or  in respect of any of the foregoing.        (q) “Notification Date” means the date of receipt by the Company of written notice from  Indemnitee advising the Company of the final disposition of the applicable Indemnifiable Claim  or portion thereof to which such Indemnifiable Losses are related, out of which such  Indemnifiable Losses arose or from which such Indemnifiable Losses resulted.           (r) “Other Indemnity Provisions” means, collectively, (i) the Constituent Documents, (ii) the  substantive laws of Ohio, and (iii) any other contract to which both Indemnitee and the  Company, STERIS, STERIS UK and any other Subsidiary of STERIS are a party, including but  not limited to the STERIS Deed and the STERIS UK Deed.        (s) “Person” means a “Person” within the meaning of Section 3(a)(9) of the Exchange Act, as  modified and used in Sections 13(d) and 14(d) thereof, except that such term shall not include (i)  the Company, STERIS or any of their respective Subsidiaries; (ii) a trustee or other fiduciary  holding securities under terms of an employee benefit and compensation plans, agreements,  arrangements, programs, policies, practices, contracts or agreement of STERIS and/or any of its  Affiliates (collectively, “Benefit Plans”); (iii) an underwriter temporarily holding securities  pursuant to an offering by STERIS or an Affiliate of STERIS of such securities; or (iv) an Entity  owned, directly or indirectly, by the shareholders of STERIS in the same proportions as their  ownership of issued shares of STERIS.           (t) “Standard of Conduct Determination” means a determination of whether Indemnitee has  satisfied any applicable standard of conduct under Ohio law that is a legally required condition  precedent to indemnification of Indemnitee under this Agreement against Indemnifiable Losses  relating to, arising out of or resulting from an Indemnifiable Claim.      (u) “STERIS Deed” means a Deed of Indemnification executed or to be executed between STERIS  and an officer or director.         (v) “STERIS UK” means STERIS Limited, a company organized under the laws of England and  Wales and formerly named STERIS plc.     (w) “STERIS UK Deed” means a Deed of Indemnification executed or to be executed between  STERIS UK and an officer or director.         (x) “Subsidiary” means an entity in which a person directly or indirectly beneficially owns 50% or  more of the total combined voting power of securities entitled to vote generally in the election of  directors.         2. Indemnification Obligation. Subject to Section 8, the Company will indemnify, defend and hold harmless  Indemnitee, to the fullest extent permitted or required by the laws of the State of Ohio in effect on the date  hereof or as such laws may from time to time hereafter be amended to increase the scope of such permitted  or required indemnification, against any and all Indemnifiable Claims and Indemnifiable  Losses; provided, however, that (a) except as provided in Sections 4 and 22, Indemnitee will not be entitled  

 

NAI-1509358470v3     6    to indemnification pursuant to this Agreement in connection with any Claim (i) initiated by Indemnitee  against the Company or any director or officer of the Company unless the Company has joined in or  consented to the initiation of such Claim or (ii) in which judgment is rendered against Indemnitee for an  accounting of profits made from the purchase or sale of securities of STERIS pursuant to the provisions of  Section 16(b) of the Exchange Act, and (b) no repeal or amendment of any law of the State of Ohio shall in  any way diminish or adversely affect the rights of Indemnitee pursuant to this Agreement in respect of any  occurrence or matter arising prior to any such repeal or amendment.        3. Advancement of Expenses Incurred with Respect to Indemnifiable Claims. Indemnitee will have the  right to advancement by the Company prior to the final disposition of any Indemnifiable Claim of any and  all Expenses relating to, arising out of or resulting from any Indemnifiable Claim paid or incurred by  Indemnitee or which Indemnitee determines are reasonably likely to be paid or incurred by Indemnitee.  Indemnitee’s right to such advancement is not subject to the satisfaction of any standard of conduct and is  not conditioned upon any prior determination that Indemnitee is entitled to indemnification under this  Agreement with respect to the Indemnifiable Claim or the absence of any prior determination to the  contrary. Without limiting the generality or effect of the foregoing, within five business days after any  request by Indemnitee, the Company shall, in accordance with such request (but without duplication),  (a) pay such Expenses on behalf of Indemnitee, (b) advance to Indemnitee funds in an amount sufficient to  pay such Expenses, or (c) reimburse Indemnitee for such Expenses; provided that Indemnitee shall repay,  without interest any amounts actually advanced to Indemnitee that, at the final disposition of the  Indemnifiable Claim to which the advance related, were in excess of amounts paid or payable by  Indemnitee in respect of Expenses relating to, arising out of or resulting from such Indemnifiable Claim. In  connection with any such payment, advancement or reimbursement, if delivery of an undertaking is a  legally required condition precedent to such payment, advance, or reimbursement, the Indemnitee shall  execute and deliver to the Company an undertaking, which need not be secured and will be accepted by the  Company without reference to Indemnitee’s ability to repay the Expenses. In no event will Indemnitee’s  right to the payment, advancement or reimbursement of Expenses pursuant to this Section 3 be conditioned  upon any undertaking that is less favorable to Indemnitee than, or that is in addition to, the undertaking set  forth in Exhibit A.  The payments, advancements and reimbursements of Expenses provided for in this  Section 3 with respect to any Indemnifiable Claim shall not be in duplication of any payments,  advancements or reimbursements of Expenses made by STERIS or STERIS UK with respect to the same  Indemnifiable Claim.        4. Indemnification for Additional Expenses. The Company will indemnify and hold harmless Indemnitee  against and, if requested by Indemnitee, will reimburse Indemnitee for, or advance to Indemnitee, within  five business days of such request, any and all Expenses paid or incurred by Indemnitee or which  Indemnitee determines are reasonably likely to be paid or incurred by Indemnitee in connection with any  Claim made, instituted or conducted by Indemnitee, in each case to the fullest extent permitted or required  by the laws of the State of Ohio in effect on the date hereof or as such laws may from time to time  hereafter be amended to increase the scope of such permitted or required indemnification, reimbursement  or advancement of such Expenses for (a) indemnification or payment, advancement or reimbursement of  Expenses by the Company under any provision of this Agreement, or under any other agreement or  provision of the Constituent Documents now or hereafter in effect relating to Indemnifiable Claims, and/or  (b) recovery under any directors’ and officers’ liability insurance policies maintained by the Company or  STERIS, regardless in each case of whether Indemnitee ultimately is determined to be entitled to such  indemnification, reimbursement, advance or insurance recovery, as the case may be; provided, however,  that Indemnitee will return, without interest, any such advance of Expenses (or portion thereof) that  remains unspent at the final disposition of the Claim (including, if applicable, final payment thereof) to  which the advance related.  The indemnity, reimbursement or advancement provided for in this Section 4  in respect of Expenses shall not be in duplication of any indemnity, reimbursement or advancement made  by STERIS or STERIS UK in respect of the same Expenses.         5. Contribution. To the fullest extent permissible under applicable law in effect on the date hereof or as such  law may from time to time hereafter be amended to increase the scope of such permitted or required  indemnification, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any  reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the payment of  

 

NAI-1509358470v3     7    any and all Indemnifiable Claims or Indemnifiable Losses, in such proportion as is fair and reasonable in  light of all of the circumstances in order to reflect (a) the relative benefits received by the Company and  Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Indemnifiable Claim or  Indemnifiable Loss and/or (b) the relative fault of the Company (and its other directors, officers,  employees and agents) and Indemnitee in connection with such event(s) and/or  transaction(s);  provided that such contribution shall not be required where it is determined, pursuant to a  final disposition of such Indemnifiable Claim or Indemnifiable Loss in accordance with Section 8, that  Indemnitee is not entitled to indemnification by the Company with respect to such Indemnifiable Claim or  Indemnifiable Loss.        6. Partial Indemnity. If Indemnitee is entitled under any provision of this Agreement to indemnification by  the Company for a portion of any Indemnifiable Loss, but not for the total amount thereof, the Company  will nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.        7. Procedure for Notification. To obtain indemnification under this Agreement in respect of an  Indemnifiable Claim or Indemnifiable Loss, Indemnitee will submit to the Company a written request,  including a brief description (based upon information then available to Indemnitee) of such Indemnifiable  Claim or Indemnifiable Loss. If, at the time of the receipt of such request, the Company or STERIS has  directors’ and officers’ liability insurance in effect under which coverage for such Indemnifiable Claim or  Indemnifiable Loss is potentially available, the Company will give prompt written notice or cause STERIS  to give prompt written notice, as applicable, of such Indemnifiable Claim or Indemnifiable Loss to the  applicable insurers in accordance with the procedures set forth in the applicable policies. The Company  will provide or cause STERIS to provide to Indemnitee a copy of such notice delivered to the applicable  insurers, and copies of all subsequent correspondence between the Company or STERIS and such insurers  regarding the Indemnifiable Claim or Indemnifiable Loss, in each case substantially concurrently with the  delivery or receipt thereof by the Company or STERIS, as applicable. The failure by Indemnitee to timely  notify the Company of any Indemnifiable Claim or Indemnifiable Loss will not relieve the Company from  any liability hereunder unless, and only to the extent that, the Company did not otherwise learn of such  Indemnifiable Claim or Indemnifiable Loss and such failure is the primary cause of forfeiture by the  Company of substantial defenses, rights or insurance coverage.       8. Determination of Right to Indemnification.        (a) Circumstances in Which No Standard of Conduct Determination is Required. To the extent that  an Indemnifiable Claim or any portion thereof, including the defense of any Indemnifiable  Claim or any portion thereof or defense of any issue or matter therein, will have been resolved  successfully on the merits or otherwise in favor of Indemnitee, including through a dismissal  without prejudice, Indemnitee will be indemnified against all Indemnifiable Losses relating to,  arising out of or resulting from such Indemnifiable Claim in accordance with Section 2 and no  Standard of Conduct Determination will be required. In the event that a matter as to which there  has been a dismissal without prejudice is later revived in the same or similar form, that matter  will be treated as a new Claim for all purposes of this Agreement.        (b) Standard of Conduct Determination. To the extent that an Indemnifiable Claim or any portion  thereof, including the defense of any Indemnifiable Claim or any portion thereof or defense of  any issue or matter therein, will not have been resolved successfully on the merits or otherwise  in favor of Indemnitee, including through a dismissal without prejudice, and the provisions of  Section 8(a) are thereby inapplicable, any Standard of Conduct Determination will be made as  follows: (i) by a majority vote of the Disinterested Directors, even if less than a quorum of the  board of directors of the Company, (ii) if a majority of Disinterested Directors so direct, by  Independent Counsel, in a written opinion addressed to the board of directors of the Company, a  copy of which shall be delivered to Indemnitee or (iii) if there are no such Disinterested  Directors, by Independent Counsel, selected by the Indemnitee, subject to the reasonable  approval of the board of directors of the Company, in a written opinion addressed to the board of  directors of the Company, a copy of which shall be delivered to Indemnitee; provided, however,  

 

NAI-1509358470v3     8    that in the event that there has been a Change in Control after the date of this Agreement, all  Standard of Conduct Determinations thereafter will be made by Independent Counsel, unless  Indemnitee elects, at Indemnitee’s sole option, to have the Standard of Conduct Determination  made by the board of directors of the Company. Indemnitee and the Company will reasonably  cooperate with the person or persons making such Standard of Conduct Determination,  including providing to such person or persons, upon reasonable advance request, any  documentation or information that is not privileged or otherwise protected from disclosure and  that is reasonably available to Indemnitee and reasonably necessary to such determination. The  Company shall indemnify and hold harmless Indemnitee against and, if requested by  Indemnitee, shall reimburse Indemnitee for, or advance to Indemnitee, within five business days  of such request, any and all costs and expenses (including reasonable attorneys’ and experts’  fees and expenses) incurred by Indemnitee in so cooperating with the person or persons making  such Standard of Conduct Determination.        (c) Timing of Standard of Conduct Determination. The Company will use its reasonable efforts to  cause any Standard of Conduct Determination required under Section 8(b) to be made as  promptly as practicable. If (i) the person or persons empowered or selected under Section 8(b) to  make the Standard of Conduct Determination will not have made a determination within 30 days  after the later of (A) the Notification Date and (B) the selection of an Independent Counsel, if  such determination is to be made by Independent Counsel and (ii) Indemnitee will have fulfilled  his/her obligations set forth in the penultimate sentence of Section 8(b), then Indemnitee will be  deemed to have satisfied the applicable standard of conduct; provided that such 30-day period  may be extended for a reasonable time, not to exceed an additional 30 days, if the person or  persons making such Standard of Conduct Determination in good faith requires such additional  time for the obtaining or evaluation or documentation and/or information relating thereto.        (d) Timing of Payment. If (i) Indemnitee is entitled to indemnification hereunder against any  Indemnifiable Losses pursuant to Section 8(a), (ii) no determination of whether Indemnitee has  satisfied any applicable standard of conduct under Ohio law is a legally required condition  precedent to indemnification of Indemnitee hereunder against any Indemnifiable Losses, or  (iii) Indemnitee has been determined or deemed pursuant to Section 8(b) to have satisfied any  applicable standard of conduct under Ohio law that is a legally required condition precedent to  indemnification of Indemnitee hereunder against any Indemnifiable Losses, then the Company  will pay to Indemnitee, within five business days after the later of (x) the Notification Date and  (y) the earliest date on which the applicable criterion specified in clause (i), (ii) or (iii) of  this Section 8(d) will have been satisfied, an amount equal to the amount of such Indemnifiable  Losses.       9. Presumption of Entitlement.        (a) In making a determination of whether Indemnitee has been successful on the merits or otherwise  in defense of any Indemnifiable Claim or any portion thereof or in defense of any issue or matter  therein, the Company acknowledges that a resolution, disposition or outcome short of dismissal  or final judgment, including outcomes that permit Indemnitee to avoid expense, delay,  embarrassment, injury to reputation, distraction, disruption or uncertainty, may constitute such  success. In the event that any Indemnifiable Claim or any portion thereof or issue or matter  therein is resolved or disposed of in any manner other than by adverse judgment against  Indemnitee (including any resolution or disposition thereof by means of settlement with or  without payment of money or other consideration), it shall be presumed that Indemnitee has  been successful on the merits or otherwise in defense of such Indemnifiable Claim or portion  thereof or issue or matter therein. The Company may overcome such presumption only by its  adducing clear and convincing evidence to the contrary.       (b) In making any Standard of Conduct Determination, the person or persons making such  determination shall presume that Indemnitee has satisfied the applicable standard of conduct,  

 

NAI-1509358470v3     9    and the Company may overcome such presumption only by its adducing clear and convincing  evidence to the contrary. Any Standard of Conduct Determination that Indemnitee has satisfied  the applicable standard of conduct shall be final and binding in all respects, including with  respect to any litigation or other action or proceeding initiated by Indemnitee to enforce his or  her rights hereunder. Any Standard of Conduct Determination that is adverse to Indemnitee may  be challenged by the Indemnitee in the state or federal courts in Ohio. No determination by the  Company (including by its directors or any Independent Counsel) that Indemnitee has not  satisfied any applicable standard of conduct, other than a Standard of Conduct determination that  is adverse to Indemnitee, shall be a defense to any Claim by Indemnitee for indemnification or  reimbursement or advance payment of Expenses by the Company hereunder or create a  presumption that Indemnitee has not met any applicable standard of conduct.        (c) Without limiting the generality or effect of Section 9(b), (i) to the extent that any Indemnifiable  Claim relates to any entity or enterprise (other than the Company) referred to in clause (i) of the  first sentence of the definition of “Indemnifiable Claim”, Indemnitee shall be deemed to have  satisfied the applicable standard of conduct if Indemnitee acted in good faith and in a manner  Indemnitee reasonably believed to be in or not opposed to the interests of such entity or  enterprise (or the owners or beneficiaries thereof, including in the case of any employee benefit  plan the participants and beneficiaries thereof) and, with respect to any criminal action or  proceeding, had no reasonable cause to believe that his or her conduct was unlawful, and (ii) in  all cases, any belief of Indemnitee that is based on the records or books of account of the  Company, including financial statements, or on information supplied to Indemnitee by the  directors or officers of the Company in the course of their duties, or on the advice of legal  counsel for the Company, the board of directors of the Company, or any committee of the board  of directors of the Company, or on information or records given or reports made to the  Company, the board of directors of the Company, or any committee of the board of directors of  the Company by an independent certified public accountant or by an appraiser or other expert  selected by or on behalf of the Company, the board of directors of the Company, or any  committee of the board of directors of the Company shall be deemed to be reasonable.        10. No Adverse Presumption. For purposes of this Agreement, the termination of any Claim by judgment,  order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo  contendere or its equivalent, will not create a presumption that Indemnitee did not meet any applicable  standard of conduct or that indemnification hereunder is otherwise not permitted.        11. Non-Exclusivity. The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee  may have under any Other Indemnity Provisions; provided, however, that  to the extent that any change is  made to any Other Indemnity Provision that permits any greater right to indemnification than that provided  under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right  hereunder. The Company will not adopt any amendment to any of the Constituent Documents the effect of  which would be to deny, diminish or encumber Indemnitee’s right to indemnification under this Agreement  or any Other Indemnity Provision.        12. Liability Insurance and Funding. For the duration of Indemnitee’s service as a director and/or officer of  STERIS, and thereafter for so long as Indemnitee will be subject to any pending or possible Indemnifiable  Claim, the Company will use commercially reasonable efforts (taking into account the scope and amount  of coverage available relative to the cost thereof), or cause STERIS to use commercially reasonable efforts,  to maintain in effect policies of directors’ and officers’ liability insurance providing coverage for directors  and/or officers of STERIS that is at least substantially comparable in scope and amount to that provided by  the Company’s current policies of directors’ and officers’ liability insurance. At Indemnitee’s request, the  Company will provide or cause STERIS to provide Indemnitee with a copy of all directors’ and officers’  liability insurance applications, binders, policies, declarations, endorsements and other related materials,  and shall provide Indemnitee with a reasonable opportunity to review and comment on the same. Without  limiting the generality or effect of the two immediately preceding sentences, the Company will not  discontinue or significantly reduce or permit the discontinuance or significant reduction of the scope or  

 

NAI-1509358470v3     10    amount of coverage from one policy period to the next (i) without the prior approval thereof by a majority  vote of the Incumbent Board, even if less than a quorum, or (ii) if at the time that any such discontinuation  or significant reduction in the scope or amount of coverage is proposed there is no Incumbent Board,  without the prior written consent of Indemnitee (which consent will not be unreasonably withheld or  delayed). In all policies of directors’ and officers’ liability insurance obtained by the Company or STERIS  pursuant to this Section 12, Indemnitee will be named as an insured in such a manner as to provide  Indemnitee the same rights and benefits, subject to the same limitations, as are accorded to STERIS’s   directors and officers most favorably insured by such policy. For the avoidance of doubt, a change in  policyholders for the above insurance coverages from Company to STERIS that does not otherwise  materially change such coverage shall not constitute a reduction in the scope of coverage.          13. Subrogation. In the event of payment under this Agreement, the Company will be subrogated to the extent  of such payment to all of the related rights of recovery of Indemnitee against other persons or entities  (other than Indemnitee’s successors), including any entity or enterprise referred to in clause (i) of the  definition of “Indemnifiable Claim” in respect of such payment. Indemnitee will execute all papers  reasonably required to evidence such rights (all of Indemnitee’s reasonable Expenses, including attorneys’  fees and charges, related to such subrogation to be reimbursed by or, at the option of Indemnitee, advanced  by the Company).        14. No Duplication of Payments. The Company will not be liable under this Agreement to make any payment  to Indemnitee in respect of any Indemnifiable Losses to the extent Indemnitee has otherwise actually  received and is entitled to retain payment (net of Expenses incurred in connection therewith and any  repayment by Indemnitee made with respect thereto) under any insurance policy, the Constituent  Documents, Other Indemnity Provisions or otherwise in respect of such Indemnifiable Losses otherwise  indemnifiable hereunder.        15. Defense of Claims. The Company, STERIS and STERIS UK will be entitled to participate in the defense  of any Indemnifiable Claim or to assume the defense thereof, with counsel reasonably satisfactory to  Indemnitee; provided that if Indemnitee believes, after consultation with counsel selected by Indemnitee,  that (i) the use of counsel chosen by the Company, STERIS or STERIS UK to represent Indemnitee would  present such counsel with an actual or potential conflict, (ii) the named parties in any such Indemnifiable  Claim (including any impleaded parties) include both (a) any of the Company, STERIS and STERIS UK,  on the one hand, and (b) Indemnitee, on the other, and Indemnitee concludes that there may be one or more  legal defenses available to Indemnitee that are different from or in addition to those available to the  Company, STERIS or STERIS UK, as applicable, or (iii) any such representation by such counsel would  be precluded under the applicable standards of professional conduct then prevailing, then Indemnitee will  be entitled to retain separate counsel (but not more than one law firm plus, if applicable, local counsel in  respect of any particular Indemnifiable Claim) at the Company’s expense. Neither the Company nor  STERIS nor STERIS UK will be liable to Indemnitee under this Agreement for any amounts paid in  settlement of any threatened or pending Indemnifiable Claim effected without, as applicable, the  Company’s, STERIS’s and STERIS UK’s prior written consent. The Company will not, and, to the extent  it has assumed the defense of an Indemnifiable Claim pursuant to this Section 15, neither STERIS nor  STERIS UK will have the right to, without the prior written consent of Indemnitee, effect any settlement of  any threatened or pending Indemnifiable Claim to which Indemnitee is, or reasonably could have been  expected to be, a party unless such settlement (a) solely involves the payment of money, (b) does not  include an admission of fault of Indemnitee, (c) does not materially adversely affect the Indemnitee’s  defense in any other pending suit or proceeding involving the Company, STERIS or STERIS UK or any of  their current or former directors and officers, and (d) includes a complete and unconditional release of  Indemnitee from all liability for any Claims that are the subject matter of such Indemnifiable Claim.  Neither the Company nor Indemnitee will unreasonably withhold its consent to any proposed settlement  nor will STERIS or STERIS UK have the right to unreasonably withhold its consent to any proposed  settlement, to the extent it has assumed the defense of an Indemnifiable Claim pursuant to this Section  15; provided that Indemnitee may withhold consent to any settlement that does not provide a complete and  unconditional release of Indemnitee and provided further that the failure by the Company, STERIS or  STERIS UK, on the one hand, or the Indemnitee, on the other, to respond to a proposed settlement for a  period of more than ten consecutive business days will constitute unreasonably withholding consent. To  

 

NAI-1509358470v3     11    the fullest extent permitted by Ohio law, the Company’s, STERIS’s or STERIS UK’s assumption of the  defense of a Claim pursuant to this Section 15 will constitute an irrevocable acknowledgement by the  Company that any Expenses incurred by or for the account of Indemnitee in connection therewith are  indemnifiable by the Company under this Agreement.       16. Successors and Binding Agreement.        (a) The Company will require any successor (whether direct or indirect, by purchase, merger,  consolidation, reorganization or otherwise) to all or substantially all of the business or assets of  the Company, by agreement in form and substance reasonably satisfactory to Indemnitee and his  or her counsel, expressly to assume and agree to perform this Agreement in the same manner  and to the same extent the Company would be required to perform if no such succession had  taken place. This Agreement will be binding upon and inure to the benefit of the Company and  any successor to the Company, including any person acquiring directly or indirectly all or  substantially all of the business or assets of the Company whether by purchase, merger,  consolidation, reorganization or otherwise (and such successor will thereafter be deemed the  “Company” for purposes of this Agreement), but will not otherwise be assignable or delegatable  by the Company.       (b) This Agreement will inure to the benefit of and be enforceable by Indemnitee’s personal or legal  representatives, executors, administrators, heirs, distributees, legatees and other successors.        (c) This Agreement is personal in nature and neither of the parties hereto will, without the consent  of the other, assign or delegate this Agreement or any rights or obligations hereunder except as  expressly provided in Section 16(a) and Section 16(b). Without limiting the generality or effect  of the foregoing, Indemnitee’s right to receive payments hereunder will not be assignable,  whether by pledge, creation of a security interest or otherwise, other than by a transfer by  Indemnitee’s will or by the laws of descent and distribution, and, in the event of any attempted  assignment or transfer contrary to this Section 16(c), the Company will have no liability to pay  any amount so attempted to be assigned or transferred.        17. Notices. For all purposes of this Agreement, all communications, including notices, consents, requests or  approvals, required or permitted to be given hereunder will be in writing and will be deemed to have been  duly given when hand delivered or dispatched by electronic mail transmission (with receipt thereof  confirmed orally or electronically), or one business day after having been sent for next-day delivery by a  nationally recognized overnight courier service, addressed to the Company (to the attention of the  Secretary of the Company) and to Indemnitee at the applicable address shown on the signature page hereto,  or to such other address as any party may have furnished to the other in writing and in accordance  herewith, except that notices of changes of address will be effective only upon receipt.        18. Governing Law, Jurisdiction and Venue. The validity, interpretation, construction and performance of  this Agreement will be governed by and construed in accordance with the substantive laws of the State of  Ohio, without giving effect to the principles of conflict of laws of such State. The Company and  Indemnitee each hereby irrevocably consent to the jurisdiction and agree to the venue of the state and  federal courts in Ohio for all purposes in connection with any action or proceeding that arises out of or  relates to this Agreement and agree that any action instituted under this Agreement will be brought only in  the state or federal courts in Ohio.        19. Validity. If any provision of this Agreement or the application of any provision hereof to any person or  circumstance is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the  application of such provision to any other person or circumstance will not be affected, and the provision so  held to be invalid, unenforceable or otherwise illegal will be reformed to the extent, and only to the extent,  necessary to make it enforceable, valid or legal. In the event that any court or other adjudicative body will  decline to reform any provision of this Agreement held to be invalid, unenforceable or otherwise illegal as  contemplated by the immediately preceding sentence, the parties thereto will take all such action as may be  

 

NAI-1509358470v3     12    necessary or appropriate to replace the provision so held to be invalid, unenforceable or otherwise illegal  with one or more alternative provisions that effectuate the purpose and intent of the original provisions of  this Agreement as fully as possible without being invalid, unenforceable or otherwise illegal.       20. Prior Agreements. This Agreement will supersede and replace any and all prior indemnification  agreements between the Company and Indemnitee.        21. Miscellaneous. Except to the extent that a change in Ohio law permits broader indemnification or  advancement of expenses than is provided under this Agreement, no provision of this Agreement may be  waived, modified or discharged unless such waiver, modification or discharge is agreed to in writing  signed by Indemnitee and the Company. No waiver by either party hereto at any time of any breach by the  other party hereto or compliance with any condition or provision of this Agreement to be performed by  such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at  any prior or subsequent time. No agreements or representations, oral or otherwise, expressed or implied  with respect to the subject matter hereof have been made by either party that are not set forth expressly in  this Agreement.        22. Legal Fees and Expenses. It is the intent of the Company that Indemnitee not be required to incur legal  fees and or other Expenses associated with the interpretation, enforcement or defense of Indemnitee’s  rights under this Agreement by litigation or otherwise because the cost and expense thereof would  substantially detract from the benefits intended to be extended to Indemnitee hereunder. Accordingly,  without limiting the generality or effect of any other provision hereof, if it should appear to Indemnitee that  the Company has failed to comply with any of its obligations under this Agreement (including its  obligations under Section 3) or in the event that the Company or any other person takes or threatens to take  any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or  proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be  provided to Indemnitee hereunder, the Company irrevocably authorizes Indemnitee from time to time to  retain counsel of Indemnitee’s choice, at the expense of the Company as hereafter provided, to advise and  represent Indemnitee in connection with any such interpretation, enforcement or defense, including the  initiation or defense of any litigation or other legal action, whether by or against the Company or any  director, officer, shareholder or other person affiliated with the Company, in any jurisdiction.  Notwithstanding any existing or prior attorney-client relationship between the Company and such counsel,  the Company irrevocably consents to Indemnitee’s entering into an attorney-client relationship with such  counsel, and in that connection the Company and Indemnitee agree that a confidential relationship will  exist between Indemnitee and such counsel. Without respect to whether Indemnitee prevails, in whole or in  part, in connection with any of the foregoing, the Company will pay and be solely financially responsible  for any and all reasonable attorneys’ and related fees and expenses incurred by Indemnitee in connection  with any of the foregoing to the fullest extent permitted or required by the laws of the State of Ohio in  effect on the date hereof or as such laws may from time to time hereafter be amended to increase the scope  of such permitted or required payment of such fees and expenses.        23. Certain Interpretive Matters. Unless the context of this Agreement otherwise requires, (i) “it” or “its” or  words of any gender include each other gender, (ii) words using the singular or plural number also include  the plural or singular number, respectively, (iii) the terms “hereof,” “herein,” “hereby” and derivative or  similar words refer to this entire Agreement, (iv) the terms “Section” or “Exhibit” refer to the specified  Section or Exhibit of or to this Agreement, (v) the terms “include,” “includes” and “including” will be  deemed to be followed by the words “without limitation” (whether or not so expressed), (vi) the word “or”  is disjunctive but not exclusive, and (vii) descriptive headings of the Sections and subsections of this  Agreement are inserted for convenience only and will not control or affect the meaning or construction of  any of the provisions of this Agreement. Whenever this Agreement refers to a number of days, such  number will refer to calendar days unless business days are specified and whenever action must be taken  (including the giving of notice or the delivery of documents) under this Agreement during a certain period  of time or by a particular date that ends or occurs on a non-business day, then such period or date will be  extended until the immediately following business day. As used herein, “business day” means any day  other than Saturday, Sunday or a United States federal holiday.     

 

NAI-1509358470v3     13       24. Counterparts. This Agreement may be executed in multiple counterparts, each of which will be deemed to  be an original but all of which together will constitute one and the same agreement.    [Signatures follow.]       

 

NAI-1509358470v3     14    IN WITNESS WHEREOF, Indemnitee has executed, and the Company has caused its duly authorized  representative to execute, this Agreement as of the date first above written.        STERIS CORPORATION  5960 Heisley Road  Mentor, Ohio 44060     By:       Name:     Title:    [INDEMNITEE]  [Address]                [Indemnitee]            

 

NAI-1509358470v3     15      EXHIBIT A  UNDERTAKING  This Undertaking is submitted pursuant to the Director and Officer Indemnification Agreement,  dated                 , 20  (the “Indemnification Agreement”), between STERIS Corporation, an Ohio corporation (the  “Company”), and the undersigned. Capitalized terms used and not otherwise defined herein have the meanings  ascribed to such terms in the Indemnification Agreement.  The undersigned hereby requests [payment] [advancement] [reimbursement] by the Company of Expenses that  the undersigned [has incurred] [reasonably expects to incur] in connection with                                           (the  “Indemnifiable Claim”).  The undersigned hereby undertakes to (a) repay the [payment] [advancement] [reimbursement] of Expenses  made by the Company to or on behalf of the undersigned in response to the foregoing request to the extent it is  ultimately determined that the undersigned is not entitled to indemnification by the Company under the  Indemnification Agreement with respect to the Indemnifiable Claim and (b) return any [payment] or [advancement]  of Expenses made by the Company to or on behalf of the undersigned in response to the foregoing request to the extent  it is not ultimately used with respect to the Indemnifiable Claim.  IN WITNESS WHEREOF, the undersigned has executed this Undertaking as of this      day of  _______________, 20  .            [Indemnitee Name]Exhibit 10.1

    

    

    EXECUTIVE MEDICAL REIMBURSEMENT PLAN

     

    

    ARTICLE I - PURPOSE

     

    1.01          The purpose of the Trustco Bank Executive Medical Reimbursement Plan (the “Plan”) is to help provide full and complete health care for Participants and their current spouse and Eligible
      Dependents as defined herein.  The Plan is intended to provide reimbursement of medical, hospitalization, dental, and other similar expenses described in Article VI herein, which are not otherwise covered by insurance or provided by Trustco Bank (the
      “Company”).  All benefits paid under this plan are fully taxable to the plan Participants.

     

     ARTICLE II - PERMANENT PROGRAM OR ARRANGEMENT

     

    2.01          The Company intends that this program be a permanent program or arrangement for the exclusive benefit of its designated participants and current spouse and Eligible Dependents.  Nothing
      herein, however, shall prevent the Company from amending or terminating this Plan, provided such amendment or termination is permissible under applicable law and such amendment or termination shall not affect a claimant’s rights to benefits hereunder
      with respect to reimbursable expenses that have been incurred prior to the date Company action is taken to terminate the Plan or the effective date of such termination, whichever occurs last.

     

    2.02          The exclusive purpose of this Plan is to provide the medical benefits described herein for covered participants and their current spouse and Eligible Dependents.  No benefits payable
      under this Plan shall be applied for any other purpose.

     

     ARTICLE III - EFFECTIVE DATE

     

    3.01          The original effective date of this Plan was October 1, 1997.  The Plan was restated effective May 17, 2022. The records of the Plan shall be kept on a Plan Year basis.  The Plan Year
      shall be October 1 through September 30.

     

     ARTICLE IV - ELIGIBILITY

     

    4.01          Only those employees who are specifically designated by the Company from time to time pursuant to the following process are eligible to participate in this Plan.  To become eligible to
      participate in the Plan, an employee must be specifically designated in writing as eligible for benefits under the Plan and such designation must be authorized by the Company’s Board of Directors.

     

    
      
        

    

     ARTICLE V - PARTICIPATION

     

    5.01          Each employee who is eligible to participate in the Plan under Article IV (an “Eligible Employee”) shall become a participant in the Plan (a “Participant”) on the first day the Company
      designates him or her as an Eligible Employee under Article IV.  Amounts received that are attributable to reimbursements due the Participant’s current spouse or Eligible Dependents shall be considered to have been received by the Participant.  For
      purposes of this Plan, an “Eligible Dependent” is a dependent who would meet the coverage requirements of the health plan maintained by the Company if the Eligible Employee were covered by that plan.  For avoidance of doubt, only an Eligible
      Employee’s current spouse’s (or surviving spouse’s) claims are eligible for reimbursement.  A divorced former spouse is not eligible for benefits under this Plan and a divorced former spouse’s claims are not eligible for reimbursement.

     

    5.02          An Eligible Employee (and his or her current spouse and Eligible Dependents) will continue to be a Participant in the Plan after the Eligible Employee ceases employment with the
      Company, except if the Eligible Employee’s termination of employment is due to Good Cause.  For purposes of this Plan, “Good Cause” shall be limited to the Eligible Employee’s commission of an act of fraud, embezzlement or theft constituting a felony
      against either of the Company as finally determined by a court of competent jurisdiction or an unequivocal admission by the Eligible Employee. On the date an Eligible Employee is terminated for Good Cause, the Eligible Employee will cease to be a
      Participant in the Plan.  Any expenses incurred on or after that date by the Eligible Employee, his or her Eligible Dependents, or current spouse will not be eligible for reimbursement.

     

    5.03          If an Eligible Employee dies, the Eligible Employee’s surviving spouse will continue to be a Participant in the Plan until the surviving spouse’s death.  An Eligible Dependent of the
      decedent Eligible Employee will continue to be a Participant until the earlier of the Eligible Dependent’s death or the date the Eligible Dependent ceases to meet the coverage requirements of the health plan maintained by the Company if the Eligible
      Employee were covered by that plan.

     

     ARTICLE VI - BENEFITS

     

    6.01          The Company shall pay to each Participant such amounts as he or she had expended while a Participant for medical care for himself or herself and his or her current spouse and Eligible
      Dependents, subject to the limits described in Section 7, below.

     

    6.02          For purposes of this Plan the following terms shall have the definitions set forth below:

     

    	

          	(a)	
            “Amounts expended for medical care” means amounts paid for:

          

     

    	

          	(1)	
            hospitalization, medical and dental bills, prescription drugs and eyeglasses;

          

     

    	

          	(2)	
            medical benefits allowable as a deduction under Internal Revenue Code Section 213, without regard to any adjusted gross income limitation, and

          

     

    	

          	(3)	
            transportation primarily for, and essential to, medical care.

          

     

    
      
        

    

     ARTICLE VII - LIMITATION ON BENEFITS PROVIDED

     

    7.01          The amount a Participant shall be entitled to receive in reimbursements under this Plan for any calendar year is unlimited.  However, in order for a claim to be eligible for
      reimbursement, the Participant (and any covered spouse or Eligible Dependent) must also have current coverage under a major medical plan.  The Plan Administrator in his or her sole discretion will determine what major medical coverage will be deemed
      sufficient.

     

     ARTICLE VIII - BENEFITS FROM ANOTHER SOURCE

     

    8.01          Reimbursement under this Plan shall be made only in the event, and to the extent that reimbursement for amounts expended, or payment, for medical care is not provided for under any
      insurance policy or under any other plan of the Company or another employer or under any federal or state law.  If there is such a policy, plan or law in effect providing for such reimbursement or payment in whole or in part, then, to the extent of
      the coverage under such policy, plan or law, the Company shall be relieved of any and all liability hereunder.

     

     ARTICLE IX - CLAIMS AND CLAIMS REVIEW PROCEDURE

     

    9.01          Claims for benefits under this Plan shall be made on forms maintained by the Company.  To obtain reimbursement for medical expenses hereunder, a Participant must submit within 30 days
      after the end of each calendar quarter a request for reimbursement for medical expenses incurred by him or her during the preceding quarter, together with such evidence of payment of such expenses as shall be required by the Company in accordance
      with rules uniformly applied.

     

    9.02          If any claim for benefits under this Plan is denied in whole or in part, the Company shall promptly furnish the claimant with a written notice:

     

    	

          	(a)	
            setting forth the reason for the denial;

          

     

    	

          	(b)	
            citing the Plan provisions, upon which such denial is based;

          

     

    	

          	(c)	
            describing any additional material or information from the claimant which is necessary in order for the claimant to perfect his or her claim and why; and

          

     

    	

          	(d)	
            explaining the claim review procedure set forth herein.

          

     

    9.03          Failure by the Company to respond to a claim within a reasonable time shall be deemed a denial.  Within 60 days after denial of any claim for benefits under this Plan, the claimant may
      request in writing a review of the denial by Plan Administrator.

     

    9.04          Any claimant seeking review hereunder is entitled to examine all pertinent documents, and to submit issues and comments in writing.  The Plan Administrator shall render a decision on
      review of a claim not later than 60 days after receipt of a request for review hereunder.  The decision of the Plan Administrator on review shall be in writing and shall state the reason for the decision, referring to the Plan provisions upon which
      it is based.

     

    
      
        

    

     ARTICLE X - ADMINISTRATION

     

    10.01          The Plan Administrator is the Board of Directors’ Compensation Committee, or its designee.  The Plan Administrator shall have authority and responsibility to control and manage the
      operation and administration of this Plan.  This includes the authority to interpret all terms, provisions, conditions and limitations of the Plan and to determine all questions arising out of or in connection with the provisions of the Plan or its
      administration in any and all cases.

     

     ARTICLE XI - MISCELLANEOUS

     

    11.01          All terms expressed herein shall be deemed to include the feminine and neuter genders and all references to the plural shall be deemed to include the singular and vice versa all as
      proper construction shall dictate.

     

    11.02          To the extent not pre-empted by the Employee Retirement Income Security Act of 1974 (ERISA), as amended, questions concerning the proper interpretation of the terms of this Plan shall
      be determined in accordance with the law of the State of New York, where the Company’s principal business office is located.

     

    11.03          The Plan Administrator shall keep a copy of this plan document and any other disclosure documents relating thereto (including, but not limited to, summary plan descriptions) that are
      in the public domain on file at his office where Participants may inspect them during the Company’s regular business hours.  Upon request, the Company shall provide a Participant, current spouse, or Eligible Dependent with copies of such documents. 
      When the Administrator provides such documents, the Administrator may charge the requesting party a reasonable charge for photocopying these materials.

     

    11.04          This document contains all of the operative provisions of this Plan.  Any conflict between the provisions of this document and any other Company document purporting to explain the
      rights, benefits, or obligations of the parties hereunder shall be resolved in favor of this Plan document.  In the event that a tribunal of competent jurisdiction shall determine in a final judgement or decree that one or more of the provisions of
      this Plan is invalid due to the provisions of applicable law, this Plan shall be interpreted as if the offending language had been stricken from its provisions and the remainder of the Plan document shall continue in full force and effect.

     

    The foregoing Plan was amended, restated, and adopted by resolution of the board of directors of Trustco Bank on May 17, 2022.

     

    	 	 	
            /s/ Michael Hall

          
	 	
            MICHAEL HALL

          
	 	
            Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]